Screener
Relay Therapeutics, Inc.
RLAYRelay Therapeutics is a clinical-stage precision medicine company focused on developing small molecule therapies for oncology and genetic diseases.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.6M
EPS estimate-$0.40
Financials
Q2 2026Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Relay Therapeutics is a clinical-stage precision medicine company focused on developing small molecule therapies for oncology and genetic diseases. The company utilizes its proprietary Dynamo platform to integrate computational and experimental techniques, enabling Motion-Based Drug Design by analyzing protein dynamics rather than static structures.
Competitive position
A pioneer in motion-based drug design utilizing a proprietary computational platform to target previously undruggable protein conformations.
GeographiesUnited States
Customer segmentsPatients, Clinical trial participants
Business modelR&D intensive, Drug development
SuppliersComputational hardware providers, Laboratory equipment suppliers, Contract research organizations, Genomic data providers
CustomersHospitals, Specialty pharmacies, Oncology clinics
CountryUnited States of America
Listed2020
Employees309.0
CEOSanjiv K. Patel
SectorHealthcare
IndustryBiotechnology
Websiterelaytx.com
FilingsSEC EDGAR
FAQ
- What is Relay Therapeutics, Inc.'s market cap?
- Relay Therapeutics, Inc. (RLAY) has a market capitalization of $4.1B and trades on NASDAQ.
- What is Relay Therapeutics, Inc.'s revenue and profitability?
- Relay Therapeutics, Inc. generated $10.4M in trailing twelve-month revenue with a net loss of $286.0M, representing a net margin of -2763.6%. The latest reported period is Q2 2026.
- Who are Relay Therapeutics, Inc.'s competitors?
- Relay Therapeutics, Inc.'s key competitors include Schrödinger, Revolution Medicines, Rallybio Corporation Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Relay Therapeutics, Inc. partner with?
- Relay Therapeutics, Inc.'s notable partners include Roche, Genentech.
- Where is Relay Therapeutics, Inc. headquartered?
- Relay Therapeutics, Inc. is headquartered in United States of America and employs approximately 309 people. It has been publicly traded since 2020.
